1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Coronary Syndrome: new trials by email Literature Review of Coronary Syndrome trials Research Report on Coronary Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? Aspirin 75mg, Aspirin 20mg, Rivaroxaban 2.5 mg - Coronary Syndrome | Phase 4 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 48 | 2021-08-26 | 2026-02-20 |
Angina, Unstable (1)
Angina Pectoris (1) · Cardiovascular Diseases (1) · Chest Pain (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Vascular Diseases (1)
Aspirin (1) · Rivaroxaban (1)
Sheffield Teaching Hospitals NHS Foundation Trust (1)
United Kingdom (1)